| Accession Number | 0001193125-26-274287 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 17, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Class A Common Stock | โ | Jun 15, 2026 | Tax Withholding | 1,889 | $36.61 | $69,156.29 | 23,899 | Direct | โ | View Details | |
Chief Commercial Officer | Class A Common Stock | โ | Jun 16, 2026 | Exercise/Conversion | 100,000 | โ | โ | 123,899 | Direct | โ | View Details | |
Chief Commercial Officer | Class A Common Stock | โ | Jun 16, 2026 | Sale | 61,966 | $36.60 | $2,267,955.60 | 61,933 | Direct | โ | View Details | |
Chief Commercial Officer | Class A Common Stock | โ | Jun 16, 2026 | Sale | 38,034 | $37.05 | $1,409,159.70 | 23,899 | Direct | โ | View Details | |
Chief Commercial Officer | Class B Common Stock | โ | Jun 16, 2026 | Sale to Issuer | 100,000 | โ | โ | 365,864 | Direct | โ | View Details | |
Chief Commercial Officer | Common Units of Medline Holdings, LP | Derivative | Jun 16, 2026 | Exercise/Conversion | 100,000 | $0.00 | $0.00 | 365,864 | Indirect | See Footnote | View Details |